Chiesi announces a partnership with Abdi İbrahim in Türkiye

Chiesi Farmaceutici has announced a strategic partnership with Abdi İbrahim to implement a new operating model for Chiesi's business in Türkiye.

Effective 1 October 2026, the partnership will combine Chiesi's global scientific expertise, innovative portfolio and high-quality standards with Abdi İbrahim's strong local capabilities, market reach and nationwide commercial infrastructure. Under the new operating model, products from Chiesi Türkiye's portfolio in Respiratory Health, Neonatology and Rare Diseases will continue to be available to patients and healthcare professionals across Türkiye, reflecting Chiesi's commitment to improve people's quality of life and ensure that no patient is left behind.